Opinion
Case No.: 2:15-cv-01360-JCM-GWF
06-22-2016
Michael J. McCue (Nevada Bar #6055) Meng Zhong (Nevada Bar #12145) LEWIS ROCA ROTHGERBER LLP 3993 Howard Hughes Parkway, Suite 600 Las Vegas, NV 89169-5996 (702) 949-8200 (phone) (702) 949-8398 (facsimile) mmccue@lrrlaw.com mzhong@lrrlaw.com Mark H. Izraelewicz Thomas I. Ross Kevin M. Flowers Amanda Antons MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive, 6300 Willis Tower Chicago, IL 60606-6357 (312) 474-6300 (phone) (312) 474-0448 (facsimile) mizraelewicz@marshallip.com tross@marshallip.com kflowers@marshallip.com aantons@marshallip.com Attorneys for Plaintiffs SPECTRUM PHARMACEUTICALS, INC. and UNIVERSITY OF STRATHCLYDE Michael D. Rounds (Nevada Bar #4734) Adam Yowell (Nevada Bar #11748) BROWNSTEIN HYATT FARBER SCHRECK, LLP 5371 Kietzke Lane Reno, NV 89511 Telephone: 775.324.4100 Facsimile: 775.333.8171 mrounds@bhfs.com ayowell@bhfs.com Attorneys for Defendant ACTAVIS LLC
Michael J. McCue (Nevada Bar #6055)
Meng Zhong (Nevada Bar #12145)
LEWIS ROCA ROTHGERBER LLP
3993 Howard Hughes Parkway, Suite 600
Las Vegas, NV 89169-5996
(702) 949-8200 (phone)
(702) 949-8398 (facsimile)
mmccue@lrrlaw.com
mzhong@lrrlaw.com Mark H. Izraelewicz
Thomas I. Ross
Kevin M. Flowers
Amanda Antons
MARSHALL, GERSTEIN & BORUN LLP
233 South Wacker Drive, 6300 Willis Tower
Chicago, IL 60606-6357
(312) 474-6300 (phone)
(312) 474-0448 (facsimile)
mizraelewicz@marshallip.com
tross@marshallip.com
kflowers@marshallip.com
aantons@marshallip.com Attorneys for Plaintiffs
SPECTRUM PHARMACEUTICALS, INC.
and UNIVERSITY OF STRATHCLYDE Michael D. Rounds (Nevada Bar #4734)
Adam Yowell (Nevada Bar #11748)
BROWNSTEIN HYATT FARBER
SCHRECK, LLP
5371 Kietzke Lane
Reno, NV 89511
Telephone: 775.324.4100
Facsimile: 775.333.8171
mrounds@bhfs.com
ayowell@bhfs.com
Attorneys for Defendant ACTAVIS LLC
JUDGMENT
WHEREAS, on July 17, 2015, Plaintiffs Spectrum Pharmaceuticals, Inc. and University of Strathclyde (collectively, "Plaintiffs") commenced this action against Actavis LLC ("Actavis"), alleging infringement of U.S. Patent No. 6,500,829 ("the '829 patent") under 35 U.S.C. § 271(a), (b), (c), and (e)(2)(A) (ECF No. 1);
WHEREAS Plaintiffs and Actavis have jointly moved for final judgment in this action in accordance with the Stipulation and Order to Lift Stay (ECF No. 10) and Stipulation and Order to Enter Final Judgment (ECF No. 11).
NOW, THEREFORE, IT IS HEREBY ORDERED AS FOLLOWS:
Judgment is entered in favor of Actavis that claims 1 and 2 of the '829 patent are invalid, and claims 3, 4, and 5-14 of the '829 patent are not infringed by ANDA No. 206516 as if fully tried and adjudicated.
IT IS SO ORDERED:
/s/_________
UNITED STATES DISTRICT JUDGE
DATED: June 22, 2016